Ziopharm Oncology to Announce Fourth Quarter and Full Year 2018 Financial Results and Host Conference Call on March 5

Ads

You May Also Like

OmniSeq, Inc. to Participate in the NCI-MATCH Clinical Trial

Having Met Rigorous Qualifications, OmniSeq Becomes One of Several Commercial and Academic Laboratories Designated ...

Veritas Pharma Initiates Cancer Research with Dr. Dmitri Petchkovski

VANCOUVER, British Columbia, Nov. 14, 2017 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT); (OTC:VRTHF); ...

Pharmacokinetic Profile of Trogarzo™ Presented at IDWeek

MONTREAL, Oct. 03, 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) is pleased ...